Form 8-K - Current report:
SEC Accession No. 0001826466-24-000050
Filing Date
2024-04-15
Accepted
2024-04-15 12:36:10
Documents
17
Period of Report
2024-04-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8-k.htm   iXBRL 8-K 13205
2 EXHIBIT 21 exhibit21.htm EX-21 911
3 GRAPHIC exhibit21x1x1.jpg GRAPHIC 81811
4 GRAPHIC exhibit21x2x1.jpg GRAPHIC 67718
5 GRAPHIC exhibit21x3x1.jpg GRAPHIC 81212
  Complete submission text file 0001826466-24-000050.txt   496702

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nkph-20240410.xsd EX-101.SCH 3048
7 XBRL LABEL FILE nkph-20240410_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE nkph-20240410_pre.xml EX-101.PRE 22381
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3091
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56234 | Film No.: 24843890
SIC: 3790 Miscellaneous Transportation Equipment
(CF Office: 04 Manufacturing)